California Partnership for Access to Treatment

CPAT is a diverse network of advocacy and community groups, health care providers and employers, committed to ensuring a healthy and productive California.

[California Partnership for Access to Treatment @CaAccess]

Fungal spores carried by dust and wind may be affecting more people in California, highlighting the importance of awareness around Valley fever. https://t.co/JRt2ghIq5h

[California Partnership for Access to Treatment @CaAccess]

Health privacy forms may not always give patients an easy way to say no, raising concerns about how personal data is shared. https://t.co/PMo7bEFEXq

[California Partnership for Access to Treatment @CaAccess]

Growing concerns about ER staffing and wait times show how delays can impact patient care and overall safety. https://t.co/XwzuEXDR29

[Liver Coalition @LiverCoalition]

Recent 2026 American Diabetes Association data show that approximately 65% of adults with type 2 diabetes have MASLD — a significant increase from the long‑cited 52% estimate. Emerging evidence suggests the true prevalence may approach 70% in high‑risk subgroups.
https://t.co/sX5Tszj9i2

[California Partnership for Access to Treatment @CaAccess]

Prior authorization delays remain a challenge, leaving many patients waiting longer for care even as insurers promise improvements. https://t.co/Qm3r3KGcRz

[California Partnership for Access to Treatment @CaAccess]

A first-of-its-kind FDA-approved treatment may offer new hope for adults living with chronic hepatitis D. https://t.co/AcLm6drVK1

[California Partnership for Access to Treatment @CaAccess]

Preventing chronic disease starts with treating obesity. Restoring Medi-Cal coverage for #GLP-1 medications would help more Californians access evidence-based care while reducing the long-term costs of untreated obesity and other chronic conditions.
https://t.co/g7OtLq2GJ2

[Liver Coalition @LiverCoalition]

Registration is open for our Liver Q&A Webinar on understanding and managing MASLD/MASH (#fattyliverdisease). Featuring Dr. @MonicaTincopa and a special #GlobalFattyLiverDay panel with experts, public health, community leaders, and patient voices. Register: https://t.co/wZoed3YLA7

[California Partnership for Access to Treatment @CaAccess]

Antibiotics sold without a prescription remain a global concern, raising the risk of drug resistance and harder-to-treat infections. https://t.co/DdvON4TgxJ

[California Partnership for Access to Treatment @CaAccess]

A policy change is opening access to brain stimulation surgery for some children with severe epilepsy after one teen’s denied care was approved. https://t.co/IFg37zs3t5

[California Partnership for Access to Treatment @CaAccess]

Most Americans remained insured in 2025, but new policy changes could make it harder for some families to keep coverage next year. https://t.co/2lfFapv6Mb

[California Partnership for Access to Treatment @CaAccess]

Most cancers lack recommended screenings — meaning millions of patients don’t know they have cancer until symptoms present. #MCED is changing that. @GMA covers new #ASCO2026 findings on what this means for patients: https://t.co/tHTCkX90bX

[California Partnership for Access to Treatment @CaAccess]

More screening options could help more people catch colon cancer early, including new at-home and blood-based tests for those at average risk. https://t.co/z8H7X7JuJt

[California Partnership for Access to Treatment @CaAccess]

New research offers hope for chronic hepatitis B patients: a weekly treatment may help some people reach a functional cure. Read more: https://t.co/CWqBYcHVCe

[California Partnership for Access to Treatment @CaAccess]

California Attorney General Rob Bonta is opposing a renewed Trump administration effort to access medical records related to gender-affirming care, emphasizing the protection of patient privacy.
Read more here: https://t.co/wMaJ7uK4j5

[California Partnership for Access to Treatment @CaAccess]

The PASTEUR Act, reintroduced by members of the U.S. House of Representatives, aims to revitalize the antibiotic and antifungal development pipeline by changing how the federal government pays for novel antimicrobials.
Read more here: https://t.co/CUxq5McYgf

[California Partnership for Access to Treatment @CaAccess]

Medical misdiagnosis costs the U.S. hundreds of billions of dollars each year, placing a major financial burden on women. Who often face years of repeat appointments, tests, and prescriptions before receiving the right diagnosis.
Read more here: https://t.co/8HbNMVKuFg

[California Partnership for Access to Treatment @CaAccess]

U.S. pharmaceutical innovation is vital to patient access to treatment. As China attempts to surpass us in global bioscience - even as their patients struggle - we must uphold America’s commitment to excellence in developing lifesaving treatments. https://t.co/jokSZwUGRo

[California Partnership for Access to Treatment @CaAccess]

The newly introduced #PASTEURAct aims to revitalize the antibiotic and antifungal development pipeline by changing federal payment for novel antimicrobials.
Read more here: https://t.co/W1XXzFKHVE

[California Partnership for Access to Treatment @CaAccess]

The FTC reached a landmark settlement with Express Scripts, forcing major changes to boost transparency, lower out-of-pocket insulin costs, and bring revenue to community pharmacies.
Read more here: https://t.co/O6aHMmjWlD